|
FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer
|
18 August 2014 |
|
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
|
05 August 2014 |
|
Roche announces definitive agreement to acquire Seragon Pharmaceuticals
|
02 July 2014 |
|
Roche Children's Walk 2014
|
19 June 2014 |
|
Roche with good start in 2014
|
15 April 2014 |
|
Roche delivers strong 2013 results
|
31 January 2014 |
|
Roche and Polyphor join efforts to combat multi-drug-resistant bacterial infections
|
04 November 2013 |
|
Roche posts strong sales growth in the first nine months of 2013
|
17 October 2013 |
|
Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Science in New York City
|
09 October 2013 |
|
Christoph Franz nominated to become new Roche Chairman
|
16 September 2013 |
|
Roche halts investigation of aleglitazar
|
10 July 2013 |
|
Roche Group posts strong sales growth in the first quarter
|
11 April 2013 |
|
Roche launches new process for accessing clinical trial data
|
26 February 2013 |
|
FDA approves Roche's Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer
|
24 February 2013 |
|
Roche delivers strong 2012 results
|
31 January 2013 |
|
Roche reports positive studies of MabThera given by subcutaneous injection
|
10 December 2012 |
|
Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology
|
06 December 2012 |
|
Results from the positive phase III AVAglio study
|
18 November 2012 |
|
Roche Group posts strong sales growth in the third quarter
|
16 October 2012 |
|
Roche leads healthcare sector in key sustainability index for fourth consecutive year
|
13 September 2012 |